CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market buy Director bought 150,000 shares at $0.19 ($28,290)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Grant or award VP & Chief Financial Officer acquired 35,250 shares (grant or award)
- 8-K Event Delisting notice
- 4 Grant or award Exec VP and Chief MO acquired 47,000 shares (grant or award)
- 4 Grant or award VP & Chief Financial Officer acquired 35,250 shares (grant or award)
- 4 Grant or award President and CEO acquired 70,500 shares (grant or award)
- 8-K Event Delisting notice
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 35 of 74 · 1,465 filings